Cargando…
Selective anti-tumor activity of the novel fluoropyrimidine polymer F10 towards G48a orthotopic GBM tumors
F10 is a novel anti-tumor agent with minimal systemic toxicity in vivo and which displays strong cytotoxicity towards glioblastoma (GBM) cells in vitro. Here we investigate the cytotoxicity of F10 towards GBM cells and evaluate the anti-tumor activity of locally-administered F10 towards an orthotopi...
Autores principales: | Gmeiner, William H., Lema-Tome, Carla, Gibo, Denise, Jennings-Gee, Jamie, Milligan, Carol, Debinski, Waldemar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905194/ https://www.ncbi.nlm.nih.gov/pubmed/24346635 http://dx.doi.org/10.1007/s11060-013-1321-1 |
Ejemplares similares
-
New Agents for Targeting of IL-13RA2 Expressed in Primary Human and Canine Brain Tumors
por: Debinski, Waldemar, et al.
Publicado: (2013) -
Fluoropyrimidine Modulation of the Anti-Tumor Immune Response―Prospects for Improved Colorectal Cancer Treatment
por: Gmeiner, William H.
Publicado: (2020) -
Prognostic utility of lncRNAs (LINC00565 and LINC00641) as molecular markers in glioblastoma multiforme (GBM)
por: Amer, Rehab G., et al.
Publicado: (2022) -
Targeting Orthotopic Glioma in Mice with Genetically Engineered Salmonella typhimurium
por: Wen, Min, et al.
Publicado: (2014) -
Treatment with the PI3K inhibitor buparlisib (NVP-BKM120) suppresses the growth of established patient-derived GBM xenografts and prolongs survival in nude rats
por: Netland, I. A., et al.
Publicado: (2016)